Difficulty: Medium
Average Score: 68%
Practice
Tick the drug which belongs to nucleoside reverse transcriptase inhibitors:
Correct answer
A
Rationale
In the context of pharmacology across the lifespan, understanding antiretroviral medications is crucial for managing HIV/AIDS. Nucleoside reverse transcriptase inhibitors (NRTIs) are a class of drugs that inhibit the enzyme reverse transcriptase, essential for viral replication. Didanosine (Option A) is a NRTI that disrupts viral replication by acting as a faulty building block in the viral DNA chain.
Gancyclovir (Option B) is an antiviral medication used to treat herpes infections, not HIV. Nevirapine (Option C) is a non-nucleoside reverse transcriptase inhibitor (NNRTI), which works differently from NRTIs by binding directly to the enzyme, making it the wrong choice for this question. Vidarabine (Option D) is an antiviral medication used to treat herpes simplex and varicella-zoster infections, not HIV.
Educationally, understanding the classification of antiretroviral drugs is essential for healthcare professionals working with patients across the lifespan who are living with HIV/AIDS. Recognizing the specific mechanisms of action of each drug class helps in making informed decisions regarding treatment regimens to ensure optimal patient outcomes.
Gancyclovir (Option B) is an antiviral medication used to treat herpes infections, not HIV. Nevirapine (Option C) is a non-nucleoside reverse transcriptase inhibitor (NNRTI), which works differently from NRTIs by binding directly to the enzyme, making it the wrong choice for this question. Vidarabine (Option D) is an antiviral medication used to treat herpes simplex and varicella-zoster infections, not HIV.
Educationally, understanding the classification of antiretroviral drugs is essential for healthcare professionals working with patients across the lifespan who are living with HIV/AIDS. Recognizing the specific mechanisms of action of each drug class helps in making informed decisions regarding treatment regimens to ensure optimal patient outcomes.